Description:

Perspectives on a Career in Therapeutic Biologics Process Development – Where We’ve Been and Challenges & Opportunities for the Future

In this seminar, I’ll discuss some of my career share some of my perspectives from over two decades in numerous roles involving developing processes to produce therapeutic biologics, including how the field has developed and where I see key opportunities & challenges for the future in the context of the broader challenges for the industry. Along the way, I hope also to shed some light on what life looks like as an industrial engineer & scientist working in this field.

Biography:
Dana Andersen is the Vice President and Global Head of Project & Portfolio Management in Technical Development at Roche. His group includes technical development team leaders, project management, external manufacturing support, and CMC due diligence support for Roche’s clinical development portfolio.
Prior to his current role, he has held numerous leadership roles in various parts of process development. He joined Genentech over 22 years ago from a post-Doc at the ETH in Zurich. He received his Ph.D. from Stanford University studying the effects of cell culture factors on glycosylation, and B.S. from the University of Colorado, Boulder, both in chemical engineering.
He also serves on the Advisory Board for the journal Biotechnology & Bioengineering, has co-chaired multiple scientific conferences and held leadership roles in several scientific organizations and is a fellow of the American Institute for Medical and Biological Engineering.